Amber Dragg
Group for the Analysis of Development(PE)
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes Management and Research, Genetic Associations and Epidemiology
Most-Cited Works
- → Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2019)124 cited
- → Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)(2019)101 cited
- → Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2021)95 cited
- → The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures(2020)69 cited
- → Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience(2022)29 cited
- → Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program(2019)26 cited
- → WalkMore: a randomized controlled trial of pedometer-based interventions differing on intensity messages(2014)25 cited
- → Association of Metformin With the Development of Age-Related Macular Degeneration(2022)24 cited
- → Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors(2019)22 cited
- → Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)(2022)15 cited